The Impact of Marijuana Pharmaceuticals
6 Pages Posted: 16 Sep 2013
Date Written: September 15, 2013
Abstract
FDA will soon approve Sativex, the first marijuana-based pharmaceutical. Sativex is a tipping point in the marijuana law and the politics of strict prohibition. The reclassification of marijuana under the Controlled Substances Act is in the financial interests of the American pharmaceutical industry. The availability of marijuana-based, or synthetic cannabinoid-based, pharmaceuticals will change the politics of marijuana prohibition.
Keywords: marijuana, Sativex, cannabinoid
Suggested Citation: Suggested Citation
Alfino, John, The Impact of Marijuana Pharmaceuticals (September 15, 2013). Available at SSRN: https://ssrn.com/abstract=2326245 or http://dx.doi.org/10.2139/ssrn.2326245
Feedback
Feedback to SSRN
If you need immediate assistance, call 877-SSRNHelp (877 777 6435) in the United States, or +1 212 448 2500 outside of the United States, 8:30AM to 6:00PM U.S. Eastern, Monday - Friday.